Abera Bioscience AB is a Swedish biotech company headquartered in Stockholm. We are dedicated to develop novel vaccines and vaccine development technologies to improve health worldwide. The Company's unique expertise in Biochemistry and Molecular Microbiology is based on many years of research and has generated a patented platform technology for the development of novel vaccines. Abera brings Outer Membrane Vesicle (OMV) technology to the next level by decorating their surface with a palette of antigens at a high density. To this end, Abera has adapted a natural system for bacterial protein secretion into the most efficient and versatile system for surface display of antigens known today. Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.
View Top Employees from Abera Bioscience ABWebsite | http://www.aberabio.com |
Revenue | $5 million |
Employees | 11 (9 on RocketReach) |
Founded | 2012 |
Address | 15 Stureplan, Stockholm, Stockholm, SE |
Phone | +46 72 231 17 97 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Vaccine Delivery Platform, Business Services, Science and Engineering, Vaccine Development, Outer Membrane Vesicles (OMV), Autotransporters |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Abera Bioscience AB employee's phone or email?
The Abera Bioscience AB annual revenue was $5 million in 2024.
Maria Alriksson is the CEO of Abera Bioscience AB.
9 people are employed at Abera Bioscience AB.
Abera Bioscience AB is based in Stockholm, Stockholm.
The NAICS codes for Abera Bioscience AB are [541, 541713, 54171, 54, 5417].
The SIC codes for Abera Bioscience AB are [873, 87].